An Open-Label Food Effect Study of ZN-d5 in Healthy Female Volunteers
Latest Information Update: 10 Apr 2023
At a glance
- Drugs ZN d5 (Primary)
- Indications Acute myeloid leukaemia; Amyloid light-chain amyloidosis; Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- Sponsors K-Group Alpha
- 27 Apr 2021 New trial record